2 187

Cited 31 times in

Improving the Capture of Adverse Event Data in Clinical Trials: The Role of the International Atomic Energy Agency

Authors
 Susan E. Davidson  ;  Andy Trotti  ;  Branislav Jeremic  ;  Neiro W. da Motta  ;  Fen Nee Lau  ;  Jinsil Seong  ;  Özlem U. Ataman 
Citation
 INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, Vol.69(4) : 1218-1221, 2007 
Journal Title
 INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS 
ISSN
 0360-3016 
Issue Date
2007
MeSH
Clinical Trials as Topic/standards* ; Colorado ; Data Collection/methods ; Data Collection/standards* ; Drug-Related Side Effects and Adverse Reactions* ; Humans ; International Agencies* ; National Cancer Institute (U.S.)/standards ; Nuclear Energy ; Observer Variation ; Radiotherapy/adverse effects* ; Surveys and Questionnaires/standards ; Terminology as Topic ; United States
Abstract
PURPOSE: To report meetings of the Applied Radiation Biology and Radiotherapy section of the International Atomic Energy Agency (IAEA), organized to discuss issues surrounding, and develop initiatives to improve, the recording of adverse events (AE) in clinical trials. METHODS AND MATERIALS: A first meeting was held in Atlanta, GA (October 2004). A second meeting was held in Denver, CO (October 2005) and focused on AE data capture. The National Cancer Institute Common Terminology Criteria for Adverse Events, version 3 (CTCAE) was suggested during the first meeting as the preferred common platform for the collection and reporting of AE data in its clinical trials. The second meeting identified and reviewed the current weaknesses and variations in the capture of AE data, and proposals to improve the quality and consistency of data capture were discussed. RESULTS: There is heterogeneity in the collection of AE data between both institutions and individual clinicians. The use of multiple scoring systems hampers comparisons of treatment outcomes between centers and trials. There is often insufficient detail on normal tissue treatment effects, which leads to an underestimate of toxicity. Implementation of improved data capture was suggested for one of the ongoing IAEA clinical trials. CONCLUSIONS: There is a need to compare the quality and completeness of data between institutions and the efficacy of structured/directed vs. traditional passive data collection. Data collection using the CTCAE (with or without a questionnaire) will be investigated in an IAEA multinational trial of radiochemotherapy and high-dose-rate brachytherapy in cervical cancer.
Full Text
http://www.sciencedirect.com/science/article/pii/S0360301607008085
DOI
10.1016/j.ijrobp.2007.04.054
Appears in Collections:
1. College of Medicine (의과대학) > Dept. of Radiation Oncology (방사선종양학교실) > 1. Journal Papers
Yonsei Authors
Seong, Jin Sil(성진실) ORCID logo https://orcid.org/0000-0003-1794-5951
URI
https://ir.ymlib.yonsei.ac.kr/handle/22282913/96196
사서에게 알리기
  feedback

qrcode

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

Browse

Links